TY - JOUR
T1 - Early use of echocardiography in patients with acute pulmonary embolism
T2 - Findings from the RIETE registry
AU - Bikdeli, Behnood
AU - Lobo, José Luis
AU - Jiménez, David
AU - Green, Philip
AU - Fernández-Capitán, Carmen
AU - Bura-Riviere, Alessandra
AU - Otero, Remedios
AU - Ditullio, Marco R.
AU - Galindo, Silvia
AU - Ellis, Martin
AU - Parikh, Sahil A.
AU - Monreal, Manuel
AU - RIETE Investigators
AU - Arcelus, J. I.
A2 - Adarraga, M. D.
A2 - Aibar, M. A.
A2 - Aibar, J.
A2 - Alfonso, M.
A2 - Amado, C.
A2 - Aranda, C.
A2 - Asin, U.
A2 - Azcarate-Agüero, P. M.
A2 - Ballaz, A.
A2 - Barba, R.
A2 - Barrón, M.
A2 - Barrón-Andrés, B.
A2 - Bascuñana, J.
A2 - Blanco-Molina, A.
A2 - Camon, A. M.
A2 - Carrasco, C.
A2 - Farfán, A. I.
A2 - Fernández-Capitán, C.
A2 - Fidalgo, M. A.
A2 - Font, C.
A2 - Gil, A.
A2 - Gómez, V.
A2 - Skride, A.
A2 - Vitola, B.
N1 - Funding Information:
We express our gratitude to Sanofi Spain for supporting this Registry with an unrestricted educational grant. We also express our gratitude to Bayer Pharma AG for supporting this Registry. Bayer Pharma AG’s support was limited to the part of RIETE outside Spain, which accounts for a 24.86% of the total patients included in the RIETE Registry. During the time of this study, Dr Bikdeli was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health,
Publisher Copyright:
© 2018 The Authors.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Background—Transthoracic echocardiography (TTE) is often considered for risk stratification of patients with acute pulmonary embolism (PE). We sought to determine the contemporary utilization of early TTE (within 72 hours of PE diagnosis) and explored the association between TTE findings and PE-related mortality. Methods and Results—Data from the RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry, a multicenter registry of consecutive patients with acute PE, were used (2001-July 2017). We used a generalized linear mixed model to determine predictors of early TTE performance. Moreover, the association between 3 TTE variables (right atrial enlargement, right ventricular hypokinesis, and presence of right heart thrombi) and 30-day PE-related mortality was assessed in generalized linear mixed models adjusted for PE severity index, and other comorbidities. Among 35 935 enrollees with acute PE, 15 375 (42.8%) underwent early TTE. There was an increase in early TTE utilization rate over time (P<0.001 for trend). Younger age, female sex, enrollment in countries other than Spain, history of coronary disease, heart failure, atrial fibrillation, tachycardia, and hypotension were the main predictors of early TTE (P<0.01 for all). In multivariable analyses, right atrial enlargement (adjusted odds ratio: 3.74; 95% confidence interval, 2.10-6.66), right ventricular hypokinesis (adjusted odds ratio: 3.11, 95% confidence interval: 1.85-5.21) and right heart thrombi (adjusted odds ratio: 4.39, 95% confidence interval, 1.99-9.71) were associated with increased odds for PErelated mortality. Conclusions—Early TTE is commonly performed for acute PE and utilization rates have increased over time. Right atrial enlargement, right ventricular hypokinesis, and right heart thrombi are predictive of worse outcomes. Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT02832245.
AB - Background—Transthoracic echocardiography (TTE) is often considered for risk stratification of patients with acute pulmonary embolism (PE). We sought to determine the contemporary utilization of early TTE (within 72 hours of PE diagnosis) and explored the association between TTE findings and PE-related mortality. Methods and Results—Data from the RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry, a multicenter registry of consecutive patients with acute PE, were used (2001-July 2017). We used a generalized linear mixed model to determine predictors of early TTE performance. Moreover, the association between 3 TTE variables (right atrial enlargement, right ventricular hypokinesis, and presence of right heart thrombi) and 30-day PE-related mortality was assessed in generalized linear mixed models adjusted for PE severity index, and other comorbidities. Among 35 935 enrollees with acute PE, 15 375 (42.8%) underwent early TTE. There was an increase in early TTE utilization rate over time (P<0.001 for trend). Younger age, female sex, enrollment in countries other than Spain, history of coronary disease, heart failure, atrial fibrillation, tachycardia, and hypotension were the main predictors of early TTE (P<0.01 for all). In multivariable analyses, right atrial enlargement (adjusted odds ratio: 3.74; 95% confidence interval, 2.10-6.66), right ventricular hypokinesis (adjusted odds ratio: 3.11, 95% confidence interval: 1.85-5.21) and right heart thrombi (adjusted odds ratio: 4.39, 95% confidence interval, 1.99-9.71) were associated with increased odds for PErelated mortality. Conclusions—Early TTE is commonly performed for acute PE and utilization rates have increased over time. Right atrial enlargement, right ventricular hypokinesis, and right heart thrombi are predictive of worse outcomes. Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT02832245.
KW - Echocardiography
KW - Pulmonary embolism
KW - Trends
UR - http://www.scopus.com/inward/record.url?scp=85054535103&partnerID=8YFLogxK
U2 - 10.1161/JAHA.118.009042
DO - 10.1161/JAHA.118.009042
M3 - Article
C2 - 30371152
AN - SCOPUS:85054535103
SN - 2047-9980
VL - 7
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 17
M1 - e009042
ER -